Evidence map›Paper›PMID 34948260›Full record

ArticleInternational journal of molecular sciences2021

Apoptosis Pathways Triggered by a Potent Antiproliferative Hybrid Chalcone on Human Melanoma Cells.

Irene Rodríguez, Ester Saavedra, Henoc Del Rosario, Juan Perdomo, José Quintana, Filippo Prencipe, Paola Oliva, Romeo Romagnoli, Francisco Estévez

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Irene RodríguezDepartamento de Bioquímica y Biología Molecular, Instituto Universitario de Investigaciones Biomédicas y Sanitarias, Universidad de Las Palmas de Gran Canaria, 35016 Las Palmas de Gran Canaria, Spain.
Ester SaavedraDepartamento de Bioquímica y Biología Molecular, Instituto Universitario de Investigaciones Biomédicas y Sanitarias, Universidad de Las Palmas de Gran Canaria, 35016 Las Palmas de Gran Canaria, Spain.ORCID 0000-0002-1717-386X
Henoc Del RosarioDepartamento de Bioquímica y Biología Molecular, Instituto Universitario de Investigaciones Biomédicas y Sanitarias, Universidad de Las Palmas de Gran Canaria, 35016 Las Palmas de Gran Canaria, Spain.
Juan PerdomoDepartamento de Bioquímica y Biología Molecular, Instituto Universitario de Investigaciones Biomédicas y Sanitarias, Universidad de Las Palmas de Gran Canaria, 35016 Las Palmas de Gran Canaria, Spain.ORCID 0000-0002-0163-393X
José QuintanaDepartamento de Bioquímica y Biología Molecular, Instituto Universitario de Investigaciones Biomédicas y Sanitarias, Universidad de Las Palmas de Gran Canaria, 35016 Las Palmas de Gran Canaria, Spain.ORCID 0000-0001-8225-4538
Filippo PrencipeDipartimento di Scienze Chimiche, Farmaceutiche ed Agrarie, Via L. Borsari 46, 44121 Ferrara, Italy.
Paola OlivaDipartimento di Scienze Chimiche, Farmaceutiche ed Agrarie, Via L. Borsari 46, 44121 Ferrara, Italy.
Romeo RomagnoliDipartimento di Scienze Chimiche, Farmaceutiche ed Agrarie, Via L. Borsari 46, 44121 Ferrara, Italy.ORCID 0000-0002-6374-773X
Francisco EstévezDepartamento de Bioquímica y Biología Molecular, Instituto Universitario de Investigaciones Biomédicas y Sanitarias, Universidad de Las Palmas de Gran Canaria, 35016 Las Palmas de Gran Canaria, Spain.ORCID 0000-0002-9728-2774
Universidad de Las Palmas de Gran Canaria · ES

Funding

Agencia Canaria de Investigación, Innovación y Sociedad de la Información CEI2019/05
6 · The paper itself

Abstract

The World Health Organization reported that approximately 324,000 new cases of melanoma skin cancer were diagnosed worldwide in 2020. The incidence of melanoma has been increasing over the past decades. Targeting apoptotic pathways is a potential therapeutic strategy in the transition to preclinical models and clinical trials. Some naturally occurring products and synthetic derivatives are apoptosis inducers and may represent a realistic option in the fight against the disease. Thus, chalcones have received considerable attention due to their potential cytotoxicity against cancer cells. We have previously reported a chalcone containing an indole and a pyridine heterocyclic rings and an α-bromoacryloylamido radical which displays potent antiproliferative activity against several tumor cell lines. In this study, we report that this chalcone is a potent apoptotic inducer for human melanoma cell lines SK-MEL-1 and MEL-HO. Cell death was associated with mitochondrial cytochrome

Indexed as

ApoptosisCaspasesCell DeathCell Line, TumorChalconesCytochromes cHumansIndolesMelanomaMitochondriaPoly(ADP-ribose) PolymerasesProto-Oncogene Proteins c-bcl-2Reactive Oxygen SpeciesSignal TransductionCaspasesChalconesCytochromes cindoleIndolesPoly(ADP-ribose) PolymerasesProto-Oncogene Proteins c-bcl-2Reactive Oxygen Speciesapoptosiscaspasescytotoxicityextracellular signal-regulated kinaseshybrid chalconesmelanomamitogen-activated protein kinasereactive oxygen species

Identifiers

PMID34948260
PMCPMC8706831
OpenAlexW4200410354

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.